Compass psilocybin therapy shown to be effective in largest-ever study in depression

statnews.com/2025/06/23/compass-pathways-psilocybin-depression-treatment-meets-trial-goal

Compass Pathways said Monday it achieved its primary endpoint in an early Phase 3 readout from the largest-ever study of psilocybin for treatment-resistant depression. Yet its stock price fell 36% before the markets opened, apparently signaling investor disappointment that the effect…

This story appeared on statnews.com, 2025-06-23 19:58:28.834000.
The Entire Business World on a Single Page. Free to Use →